Header Logo

Mayra Tisminetzky

Concepts (169)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
21
2022
861
4.860
Why?
Multiple Chronic Conditions
6
2023
37
3.800
Why?
Heart Failure
12
2023
853
3.060
Why?
Patient Readmission
7
2021
421
1.610
Why?
Multimorbidity
7
2025
43
1.510
Why?
Acute Coronary Syndrome
4
2017
250
1.440
Why?
Hospitalization
13
2022
1290
1.440
Why?
Atrial Fibrillation
9
2022
805
1.420
Why?
Chronic Disease
6
2025
717
1.220
Why?
Aged
34
2025
13406
1.030
Why?
Inpatients
3
2019
292
1.010
Why?
Survivors
2
2017
150
1.000
Why?
Diabetes Mellitus
3
2022
515
0.950
Why?
Angiotensin Receptor Antagonists
4
2022
64
0.880
Why?
Angiotensin-Converting Enzyme Inhibitors
4
2022
142
0.860
Why?
Hospital Mortality
8
2018
842
0.820
Why?
Hyperkalemia
1
2022
19
0.800
Why?
Male
39
2025
27747
0.800
Why?
Massachusetts
16
2021
2019
0.780
Why?
Retrospective Studies
15
2023
6071
0.770
Why?
Aged, 80 and over
16
2023
5119
0.770
Why?
Percutaneous Coronary Intervention
4
2022
160
0.760
Why?
Age Factors
9
2021
1504
0.750
Why?
Electrocardiography
2
2015
521
0.740
Why?
Female
38
2025
30724
0.700
Why?
Acute Kidney Injury
1
2022
132
0.700
Why?
Risk Factors
15
2022
4986
0.690
Why?
Mobility Limitation
1
2020
47
0.690
Why?
Morbidity
1
2020
113
0.680
Why?
Chest Pain
2
2020
81
0.660
Why?
Humans
44
2025
59389
0.620
Why?
Independent Living
1
2018
44
0.590
Why?
Risk Assessment
7
2022
1925
0.590
Why?
Anemia
1
2019
119
0.590
Why?
Disease Management
1
2019
220
0.570
Why?
Middle Aged
20
2025
16314
0.560
Why?
Adrenergic beta-Antagonists
2
2017
147
0.550
Why?
Length of Stay
7
2017
776
0.540
Why?
Time Factors
10
2019
3615
0.520
Why?
Psychosocial Deprivation
1
2015
8
0.510
Why?
Research
1
2017
188
0.500
Why?
Patient Acceptance of Health Care
1
2020
454
0.490
Why?
Survival Rate
5
2019
801
0.470
Why?
Cardiac Catheterization
2
2022
253
0.470
Why?
Patient Discharge
6
2017
492
0.450
Why?
Follow-Up Studies
6
2019
2338
0.450
Why?
Quality of Life
6
2022
1137
0.440
Why?
Myocardial Revascularization
1
2014
71
0.430
Why?
Diabetes Complications
1
2014
100
0.430
Why?
Secondary Prevention
1
2014
151
0.420
Why?
Delivery of Health Care
1
2017
413
0.420
Why?
Forecasting
1
2014
221
0.410
Why?
Primary Prevention
1
2014
134
0.400
Why?
Platelet Aggregation Inhibitors
1
2014
211
0.390
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
204
0.390
Why?
Comorbidity
6
2020
1078
0.360
Why?
Multivariate Analysis
4
2017
902
0.360
Why?
Sex Factors
6
2020
935
0.360
Why?
Anxiety
2
2020
387
0.340
Why?
Treatment Outcome
8
2017
5281
0.320
Why?
Frailty
2
2022
124
0.310
Why?
Anxiety Disorders
1
2011
186
0.310
Why?
Caregivers
2
2025
231
0.310
Why?
Cardiovascular Diseases
1
2016
789
0.310
Why?
Chi-Square Distribution
4
2017
409
0.300
Why?
Stroke
4
2022
1127
0.300
Why?
Depressive Disorder, Major
1
2011
246
0.290
Why?
Cause of Death
2
2019
210
0.290
Why?
United States
5
2025
7426
0.280
Why?
Depression
2
2020
829
0.260
Why?
Coronary Artery Bypass
3
2022
275
0.250
Why?
Prognosis
5
2017
1597
0.240
Why?
Cohort Studies
5
2018
2375
0.220
Why?
Prevalence
2
2019
1253
0.220
Why?
Potassium
1
2022
100
0.200
Why?
Medical Records, Problem-Oriented
1
2021
13
0.180
Why?
Adult
7
2025
15683
0.180
Why?
Parents
1
2025
367
0.180
Why?
Early Detection of Cancer
1
2024
266
0.180
Why?
Sleep Apnea, Obstructive
1
2022
54
0.180
Why?
Colorectal Neoplasms
1
2024
263
0.180
Why?
Anticoagulants
2
2022
480
0.180
Why?
Needs Assessment
1
2021
187
0.170
Why?
Frail Elderly
1
2020
107
0.160
Why?
Hemorrhage
1
2021
260
0.160
Why?
Antiviral Agents
1
2022
313
0.160
Why?
Adaptation, Psychological
2
2012
259
0.160
Why?
Musculoskeletal Diseases
1
2020
101
0.160
Why?
Osteoarthritis
1
2020
131
0.150
Why?
Prospective Studies
4
2022
3067
0.150
Why?
Incidence
3
2018
1238
0.140
Why?
Logistic Models
3
2016
1234
0.140
Why?
Disease-Free Survival
1
2017
228
0.140
Why?
Drug Interactions
1
2017
115
0.140
Why?
Surveys and Questionnaires
3
2022
2516
0.130
Why?
Patient Care Management
1
2016
30
0.130
Why?
Renal Insufficiency, Chronic
1
2017
114
0.130
Why?
Lung Diseases
1
2017
170
0.130
Why?
Patient Outcome Assessment
1
2016
52
0.130
Why?
Health Services Research
1
2017
266
0.130
Why?
Georgia
1
2015
87
0.120
Why?
Hypolipidemic Agents
1
2015
25
0.120
Why?
Diuretics
1
2015
59
0.120
Why?
Calcium Channel Blockers
1
2015
56
0.120
Why?
Multicenter Studies as Topic
1
2015
130
0.120
Why?
Electronic Health Records
1
2018
342
0.120
Why?
Self Report
3
2022
359
0.120
Why?
Health Status
1
2017
426
0.120
Why?
Aging
1
2020
710
0.110
Why?
Stroke Volume
1
2015
314
0.110
Why?
Longitudinal Studies
1
2017
1189
0.110
Why?
Personality Inventory
2
2011
54
0.100
Why?
Academic Medical Centers
1
2015
308
0.100
Why?
Aspirin
1
2014
167
0.100
Why?
Predictive Value of Tests
1
2015
1027
0.100
Why?
Cooperative Behavior
1
2013
210
0.090
Why?
Models, Psychological
1
2012
94
0.090
Why?
Cross-Sectional Studies
2
2025
2380
0.090
Why?
Case-Control Studies
1
2014
1051
0.090
Why?
Angina, Unstable
1
2011
57
0.090
Why?
Pediatrics
1
2013
241
0.090
Why?
Psychiatric Status Rating Scales
1
2012
379
0.090
Why?
Fear
1
2011
65
0.090
Why?
Body Mass Index
1
2014
831
0.080
Why?
Mental Health Services
1
2013
269
0.080
Why?
Severity of Illness Index
1
2015
1479
0.080
Why?
Health Services Accessibility
1
2013
527
0.080
Why?
Sex Distribution
2
2018
244
0.070
Why?
Age Distribution
2
2018
249
0.070
Why?
Geriatric Assessment
2
2020
159
0.070
Why?
Behavioral Risk Factor Surveillance System
1
2024
43
0.060
Why?
Health Surveys
1
2025
298
0.050
Why?
Monoamine Oxidase Inhibitors
1
2002
10
0.050
Why?
Antidepressive Agents, Tricyclic
1
2002
19
0.050
Why?
Fluoxetine
1
2002
44
0.050
Why?
Odds Ratio
2
2015
746
0.050
Why?
Acute Disease
2
2015
658
0.050
Why?
Perception
1
2022
168
0.050
Why?
Antidepressive Agents
1
2002
212
0.050
Why?
Patient Reported Outcome Measures
1
2021
126
0.040
Why?
Depressive Disorder
1
2002
279
0.040
Why?
Activities of Daily Living
1
2020
289
0.040
Why?
Cognition
1
2022
454
0.040
Why?
Social Support
1
2020
355
0.040
Why?
Patient-Centered Care
1
2020
246
0.040
Why?
Urban Health
1
2015
40
0.030
Why?
Cardiotonic Agents
1
2015
50
0.030
Why?
Exercise
1
2022
883
0.030
Why?
Young Adult
1
2025
4272
0.030
Why?
Shock, Cardiogenic
1
2015
85
0.030
Why?
Confidence Intervals
1
2013
241
0.030
Why?
Checklist
1
2013
72
0.030
Why?
Analysis of Variance
1
2013
589
0.020
Why?
Survival Analysis
1
2013
554
0.020
Why?
Proportional Hazards Models
1
2013
674
0.020
Why?
Guideline Adherence
1
2013
292
0.020
Why?
Edema
1
2010
42
0.020
Why?
Dyspnea
1
2010
116
0.020
Why?
Health Care Surveys
1
2010
278
0.020
Why?
Practice Guidelines as Topic
1
2013
705
0.020
Why?
Adolescent
2
2013
5838
0.020
Why?
Cough
1
2010
183
0.020
Why?
Mass Screening
1
2013
648
0.020
Why?
Practice Patterns, Physicians'
1
2010
692
0.010
Why?
Child
1
2013
4189
0.010
Why?
Postmenopause
1
2002
224
0.010
Why?
Dose-Response Relationship, Drug
1
2002
805
0.010
Why?
Double-Blind Method
1
2002
715
0.010
Why?
Randomized Controlled Trials as Topic
1
2002
678
0.010
Why?
Tisminetzky's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (169)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_